key: cord-0779763-26xeihph authors: Carvalho, A. S.; Brito Fernandes, O.; de Lange, M.; Lingsma, H.; Klazinga, N.; Kringos, D. title: Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review date: 2022-02-26 journal: nan DOI: 10.1101/2022.02.23.22271303 sha: da1d9e6c3248868562116a68b5800a0c81172542 doc_id: 779763 cord_uid: 26xeihph Objectives: Summarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020), and to assess changes in the quality of care as assessed via selected indicators. Methods: Scoping review. Indicators and their reported trends were collated following the cancer care pathway. Results: Database searches retrieved 6277 articles, 838 articles met the inclusion criteria, and 135 articles were included after full-text screening, from which 917 indicators were retrieved. Indicators assessing the diagnostic process showed a decreasing trend: from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic (n=30 indicators, 91%). A reduction was also observed in the number of diagnostic procedures (n=64, 58%) and in the diagnoses (n=130, 89%). The proportion of diagnoses in the emergency setting and waiting times showed an increasing trend (n=8, 89% and n=14, 56%, respectively). Nine indicators (64%) showed stability in cancer stages distribution. A decreasing trend in the proportion of earliest stage cancers was reported by 63% of indicators (n=9), and 70% (n=43) of indicators showed an increasing trend in the proportion of advanced-stage cancers. Indicators reflecting the treatment process signalled a reduction in the number of procedures: 79% (n=82) of indicators concerning surgeries, 72% (n=41) of indicators assessing trends in radiotherapy, and 93% (n=40) of indicators related to systemic therapies. Modifications in cancer treatment were frequently reported: 64% (n=195) of indicators revealed changes in treatment. Ten indicators (83%) signalled a decreasing number of hospital admissions. Conclusion: Health systems struggled to ensure continuity of cancer care. As this pandemic keeps evolving, the trends reported over the first 6 months of 2020 provide an argument to monitor these changes closely. This information needs to be transparent, standardised, and timely, allowing to monitor quality and outcomes of care during crises and inform policy responses. Methods 107 We conducted a scoping review, following Arksey and O'Malley methodological framework [26] , 108 further developed by Levac et al [27] . Given the lack of standardized methods across countries for 109 data collection on health care system performance assessment and their translation to indicators 110 [25, 28] , a scoping review methodology allows to map the large sums and heterogeneity of literature 111 available [27, 29, 30] and to identify key concepts present in the literature [30] , namely cancer care 112 performance indicators. It also enables the reporting of emerging evidence [29] , to summarize, and 113 communicate findings [26] , including trends revealed by indicators. The PRISMA extension for 114 scoping reviews [31] was used for reporting (S1 Table) . 115 116 Eligibility criteria of studies 117 We considered the following inclusion criteria: 1) studies using empirical data on the use of health 118 services in OECD countries, 2) studies that described health outcomes and/or performance indicators 119 related with NCD during the COVID-19 pandemic, 3) original journal articles using quantitative or 120 qualitative methods (cohort studies, case-control, cross-sectional, case reports, systematic reviews, 121 surveys, and meta-analyses). Studies were excluded if they did not provide empirical data on health 122 services and NCD, namely: 1) editorials and commentaries, 2) prediction models is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 26, 2022. ; https://doi.org/10.1101/2022.02.23.22271303 doi: medRxiv preprint were conducted to identify a list of suitable search terms. An experienced medical information 132 specialist was consulted to improve the search strategy, which was refined with discussion among co-133 authors. The comprehensive search included search terms grouped by key concepts 134 pandemic, non-communicable disease, chronic disease, performance indicator, healthcare quality, 135 healthcare utilization, healthcare delivery and other closely related terms). The search was adapted to 136 both databases and conducted by the information specialist on 17-03-2021. The full search strategy for 137 Embase can be found in S2 Doc. Duplicates were removed using EndNote software. Additional articles 138 of relevance were added by hand-searching the reference lists of the included studies. 139 140 Selection of sources of evidence 141 Titles and abstracts screening was performed independently by two researchers (ASC, OBF) using 142 Rayyan [32] . Studies considered relevant were exported to a spreadsheet to support full-text screening. 143 For this study, only articles related to cancer care were analysed. Full-text screening was performed 144 independently by two researchers (ASC, MdL). The reason for the exclusion of articles was recorded 145 at this point, and both researchers agreed on the excluded studies. In case of doubt, the other co-authors 146 were consulted. 147 148 Data extraction 149 Data extracted was collated in a spreadsheet (S3 Table) piloted on 15 studies. Prior to extracting data 150 from all studies, two researchers (ASC, MdL) compared data collected from 10 selected articles with 151 the objective of enhancing data extraction consistency among researchers. Then, data was charted 152 independently by ASC and MdL. Extracted data included information on generic and methodological 153 8 157 158 We grouped and categorised the indicators following clinical reasoning. These categories were 159 organized according to the different phases of the cancer care pathway: early detection, diagnosis, 160 treatment, and outcomes. Quantitative indicators' trends were collated, and the percentage of indicators 161 reporting each trend (increase/decrease/stable) was computed for each category. This evidence is 162 presented in the text of this study and in a diagram informing about each phase of the cancer care 163 pathway. Qualitative information extracted from surveys is presented in the text, and it was not 164 considered to compute trends. In the category "changes in treatment" quantitative indicators and 165 qualitative information were grouped and categorized according to clinical reasoning to present an 166 overview of the modifications in cancer treatment reported. 167 168 169 . CC-BY 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Database searches retrieved 6277 articles. Of these articles, 838 met the inclusion criteria, from which 171 197 articles on cancer care were identified. Eight records were identified via hand-searching. After 172 full-text screening, 135 articles were included in this study (Fig. 1) . 173 174 . CC-BY 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 10 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 Reports sought for retrieval (n = 8) Reports not retrieved (n = 0) In total, 135 studies were included, reporting on 94 countries (S4 Table) . Of these studies, 26 (19%) 210 provided information on multiple countries, from which 14 (10%) specified all the countries included. 211 Of those, 8 (6%) included non-OECD countries. Most of the studies including more than one country 212 were surveys (n=23, 89%). The most frequent countries reported on were Italy (n=36, 29%), US (n=32, 213 26%) and UK (n=27, 22%) (Fig. 2) . Most articles used a retrospective cohort design (n=82, 61%), 214 followed by surveys (n=44, 33%). Surveys were often directed to health professionals (n=37/44, 84%) 215 and to patients (n=6/44, 14%) to a lesser extent. Other study designs that were applied included 216 prospective cohorts (n=5), observational retrospective cohorts (n=3), and a combination of prospective 217 and retrospective cohort (n=1). Studies reported indicators' trends during the first phase of the COVID-218 19 pandemic (from January to June 2020) and, in some cases, after the (in many countries 219 implemented) lockdown period (from May to October 2020). The magnitude of each indicator in 2020 220 was compared with its magnitude in the same period of 2019 (n=51, 38%), to a period immediately 221 before (n=33, 24%) or to the average of the same period in previous years (ranging from 2017 to 2019) 222 (n=26, 19%). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 26, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 26, 2022. showed patients presenting in a more severe clinical condition than before the pandemic, namely in 313 US (endometrial cancer), Portugal (hepatocellular carcinoma), Italy, and Turkey (colorectal cancer). 314 The following stage of the care pathway reported on is cancer treatment. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Regarding the "volume of cancer treatment", indicators regarding the 3 main therapeutic components 330 were reported: surgeries and loco-regional therapies, radiotherapy, and systemic therapy. 331 Concerning surgeries and loco-regional therapies, 106 indicators were identified from 30 articles 332 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 26, 2022. information on telemedicine use, from which ten were international studies. Three were patients' 404 surveys. All the survey-based information and quantitative indicators reported an increase in the use 405 of telehealth to provide cancer care. One article [160] assessed patient and providers' satisfaction 406 regarding the use of telemedicine in rehabilitation of cancer patients. The proportion of patients that 407 provided good feedback ranged from 63% to 84%, and the physicians' perspective was also 408 satisfactory, ranging from 66% to 83% of physicians reporting positive feedback. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint While some of these care modifications could be learning opportunities for the future, this information 461 should be standardised, transparent, and timely, allowing to appraise the modifications in care provided 462 during crises regarding access, quality, and outcomes. 463 The increase in telemedicine utilization we report is a generalized trend across a range of medical 464 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 26, 2022. ; https://doi.org/10.1101/2022.02.23.22271303 doi: medRxiv preprint from January to June 2020, which constitutes an innovative approach to assess changes in healthcare 479 performance. 480 Our study has some limitations. The heterogeneity of study designs, populations, diseases, indicators, 481 and indicators' definitions do not allow application of a meta-analysis approach and quantifying the 482 real impact of the pandemic on cancer care. We also recognize potential bias that could arise from the 483 inclusion of survey data, which rely on what respondents recall and report. However, a relevant number 484 of surveys were conducted by international societies and networks of providers, which allows for the 485 collection of credible information regarding changes in care. Surveys also show how medical societies 486 and countries were unable to obtain these data using current health information systems and data 487 structures. We acknowledge the patients' perspective is not comprehensive since only a few surveys 488 included patient-reported outcomes and experiences of care measures. The cancer care pathway is not 489 complete in this study, as it did not address primary prevention, rehabilitation, and palliative care. 490 Nonetheless, we provide a thorough overview of the cancer care pathway, from diagnosis to outcomes. 491 The distribution of studies per country is not homogenous in this study, which does not allow to 492 generalize these trends to all included countries or to fully assess disparities in cancer care between 493 OECD countries. Care inequalities could have been exacerbated during this pandemic, which needs to 494 be further studied regarding cancer care. are presented daily to the public since the beginning of 2020. Additional and considerable efforts are 499 needed to expose the effects caused by this pandemic in non-COVID-19 care, and some of the 500 indicators we present could be useful to convey that message. 501 As new waves keep evolving, it is crucial to monitor performance indicators, such as shifts in cancer 502 staging or worsening of outcomes, closely and promptly. Also, the link between structure, process, and 503 (short-and long-term) outcome indicators should be undertaken to allow an accurate and timely 504 . CC-BY 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Our results provide a summary of performance indicators used in the literature to assess the cancer 513 care pathway from January 2020 to June 2020, and the changes in the quality of care signalled by these 514 indicators. This study shows that health systems struggled to ensure the continuity in the quality of 515 care to cancer patients in OECD countries. This information could inform on the bottlenecks of the 516 cancer care pathway and contribute to identifying disparities between and within countries, as well as 517 moments for intervention during the evolving pandemic and in future crises. Further research and 518 investment are necessary to generate system-wide oriented intelligence and strengthen data 519 infrastructures worldwide, to support timely and adequate health policy responses. 520 521 . CC-BY 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 26, 2022. ; https://doi.org/10.1101/2022.02.23.22271303 doi: medRxiv preprint Pandemic on Cancer-Related Patient Encounters Cancer Screening Tests 640 and Cancer Diagnoses During the COVID-19 Pandemic Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care pandemic during Spain's state of emergency on the diagnosis of colorectal cancer Referral pattern for urologic 649 malignancies before and during the COVID-19 pandemic Two-month stop in 652 mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront 653 treatment in the COVID era Impact of COVID-19 on Cancer 655 Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors Breast imaging, breast surgery, and cancer genetics in the 660 age of COVID-19 Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic 663 procedures The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future 666 Perspectives Impact of COVID-19 Pandemic 668 on Colorectal Cancer Screening Program CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study The impact of the coronavirus disease 2019 673 pandemic on elective urological procedures in Australia Effects of COVID-19 pandemics in a Breast unit Impact of COVID-19 on small biopsy diagnostic procedures 677 and cancer resection surgeries in the North-West of Ireland Impact of COVID-680 19 on the management of hepatocellular carcinoma in a high-prevalence area COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic 684 in Lombardy (Italy) Impact 686 of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective 687 endoscopy database COVID-19 national containment on activities in the French northern comprehensive cancer center Practice patterns of diagnostic upper gastrointestinal endoscopy 692 during the initial COVID-19 outbreak in England The impact of coronavirus 694 disease 2019 on surveillance colonoscopies in South Australia The impact of the COVID-19 pandemic on colorectal cancer 696 service provision Impact of the COVID-19 pandemic on UK 698 endoscopic activity and cancer detection: a National Endoscopy Database Analysis Impact of COVID-19 on cancer 701 diagnosis and management in Slovenia -preliminary results Fewer cancer diagnoses during the COVID-19 epidemic according to diagnosis, age and region. TSG -Tijdschr Voor A significant 706 reduction in the diagnosis of melanoma during the COVID-19 Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic Changes in the Number of US Patients With Newly 713 Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic Changing practice 716 patterns in head and neck oncologic surgery in the early COVID -19 era Global impact 719 of the COVID-19 pandemic on cytopathology practice: Results from an international survey of 720 laboratories in 23 countries Delayed melanoma diagnosis 722 in the COVID-19 era: increased breslow thickness in primary melanomas seen after the COVID-19 Eur Acad Dermatol Venereol Dermatologic Oncology and Histopathology at a 726 Secondary Care Centre During the Coronavirus Disease 2019 Pandemic Endometrial Cancer Detection During the Coronavirus 729 Disease 2019 (COVID-19) Pandemic SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a 732 report from the Italian Association for Neuroendocrine Tumors (Itanet) en el diagnóstico precoz del melanoma The COVID-19 pandemic and impact on breast 737 cancer diagnoses: what happened in England in the first half of 2020 The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution 740 experience The 742 impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands pandemic on eye cancer care in United Kingdom Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey 755 (COVID-CNSMDT Study) Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Impact of delay in follow-760 up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub 761 hospital The impact of COVID-19 on head and neck 763 cancer diagnosis and disease extent The magnitude 765 of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers Pandemic effect on Cytopathology Practice: Results from 23 Laboratories in 11 Countries Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives DElayed COloRectal cancer care during COVID-19 Pandemic (DECOR-19): Global perspective from 775 an international survey Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic Professional Assessment of the 779 Impact of COVID-19 on Handling NET Patients The impact of the first 781 peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national 782 survey Reduction in skin cancer diagnoses in the UK during the COVID-784 19 pandemic The effect 786 of the COVID-19 pandemic on skin cancer surgery in the United Kingdom: a national, multi-centre, 787 prospective cohort study and survey of Plastic Surgeons The impact of coronavirus disease 2019 on head and 789 neck cancer services: a UK tertiary centre study Impact of the COVID-19 791 pandemic on the detection and management of colorectal cancer in England: a population-based study Workload changes during the COVID-19 pandemic and 794 effects on the flow of cancer patients in the Maxillofacial Surgery Department Available from: 94. Vissio E Analysis of the surgical pathology caseload of a 799 tertiary referral hospital in Northwestern Italy Impact of COVID-19 on melanoma 801 diagnosis COVID-19 sur les prises en charge pour cancer du sein et gynécologique. Bull Cancer (Paris) The Covid-19 Pandemic Constraints May Lead to Disease Progression for Patients with Liver Cancer Scheduled to Receive 807 Locoregional Therapies: Single-Centre Retrospective Analysis in an Interventional Radiology Unit Maintaining surgical care 810 delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological 811 cancer centre Upper 813 gastrointestinal stenting during the SARS-CoV-2 outbreak: impact of mitigation measures and risk of 814 contamination for patients and staff Outbreak on Emergency Surgeries for Occlusive Colorectal Cancers Impact of the 822 first month of Covid-19 lockdown on oncologic surgical activity in the Ile de France region university 823 hospital otorhinolaryngology departments COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective 827 The impact of 829 national non-pharmaceutical interventions pandemic on the short-term survival of patients with cancer in Northern Portugal Impact of the COVID-19 outbreak on cancer patient flow 837 and management: experience from a large university hospital in Spain Impact of the COVID-19 pandemic in cancer diagnosis 839 in the first and second waves in one of the most affected cancer areas in the city of COVID-19 pandemic on practice in European radiation oncology centers Collateral effects of the coronavirus 848 disease 2019 pandemic on lung cancer diagnosis in Korea Organisational 850 challenges, volumes of oncological activity and patients' perception during the severe acute respiratory 851 syndrome coronavirus 2 epidemic Impact of the COVID-19 pandemic on specialty community practices: 853 an oncology perspective Impact of COVID-19 on Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective Medium-and Long-Term Impact of the COVID-19 Outbreak in Oncology Impact of COVID-19 on Mohs micrographic surgery: UK-864 wide survey and recommendations for practice Daily 866 Routine and Access to Care: Initial Patient Reported Experiences at a German Lung Cancer Center 118 Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study The impact of SARS-CoV-2 infection on the surgical management of colorectal cancer: Lessons learned from a 876 multicenter study in Spain Pandemic Surge on Radiation Treatment: Report From a Multicenter New York Area Institution Flattening the curve in oncologic surgery: Impact of Covid-19 on surgery at 882 tertiary care cancer center Uroonkologische Therapie in der ersten Welle der COVID-19-Pandemie: Was sagen uns die Krebsregister der deutschen Bundesländer Decreasing access to cancer diagnosis and treatment 887 Pancreatic Surgery During the COVID-19 Pandemic Northern Italy: lessons learned from a multicentric snapshot The 897 impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer Overview of the 900 italian experience in surgical management of bladder cancer during first month of Ramallo Solía I. Impact of the pandemic on surgical 904 activity in colorectal cancer in Spain. Results of a national survey Oncological colorectal 906 surgery during the COVID-19pandemic-a national survey Changes in 908 breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of 909 the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). The Breast pandemic on patients suffering from musculoskeletal tumours The Impact of the Acute Phase of COVID-19 on The impact of the COVID-919 19 pandemic on radiotherapy services in England, UK: a population-based study Palliative Radiotherapy During the Last Month 922 of Life: Have COVID-19 Recommendations Led to Reduced Utilization? Catching the Wave: Quantifying the Impact 924 of COVID on Radiotherapy Delivery The effect of clinical decision 926 making for initiation of systemic anticancer treatments in response to the COVID England: a retrospective analysis The impact of COVID-929 19 on systemic anticancer treatment delivery in Scotland COVID-19 Pandemic on Cancer Care: A Global Collaborative Study Coronavirus Disease of 2019 Pandemic on Radiation Oncology Clinical Decision Making in a High Postponing 937 elective surgery due to COVID-19 did not decrease the oncological surgery rate in Finland Effects of COVID-19 on 940 the 2-week-wait dermatology services at a regional centre between 2019 and 2020 The impact of coronavirus disease 943 2019 on the practice of thoracic oncology surgery: a survey of members of the European Society of Thoracic Surgeons (ESTS) Reduction in skin cancer 946 diagnosis, and overall cancer referrals, during the COVID-19 pandemic Assessing 949 the impact of COVID-19 on liver cancer management (CERO-19) Impact of COVID-19 in 951 gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups Insights from a 960 global snapshot of the change in elective colorectal practice due to the COVID-19 pandemic Impact of the 963 coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer Change in practice in gynecologic oncology during the COVID-19 966 pandemic: a social media survey Changes in Lung Cancer Treatment as a Result of the Influence of the pandemic 970 dissemination of COVID-19 on radiotherapy practice: A flash survey in Germany Patient and provider-reported 983 satisfaction of cancer rehabilitation telemedicine visits during the COVID-19 pandemic Impact of COVID-19 State 986 of Emergency restrictions on presentations to two Victorian emergency departments Lockdown in Surgical Emergency Accesses: Experience of a COVID-19 Hospital Indirect acute 992 effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study Changes in the top 25 995 reasons for primary care visits during the COVID-19 pandemic in a high-COVID region of Canada Impact of the COVID-19 pandemic on cancer care in OECD countries Health Working Paper Telemedicine in 1000 rheumatology: a mixed methods study exploring acceptability, preferences and experiences among 1001 patients and clinicians Eye Care Utilization During the COVID-19 Pandemic The impact of the UK: a national, 1006 population-based, modelling study The impact of treatment delay on skin cancer in COVID-19 era: a case-control study Dutch delay care for cancer, heart patients Overwhelmed by Omicron surge, U.S. hospitals delay surgeries 1013 European Cancer Organization International Agency for Research on Cancer WHO. Global Cancer Observatory